Edition:
United Kingdom

People: Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

4.28USD
18 Sep 2019
Change (% chg)

-- (--)
Prev Close
$4.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
34,551
52-wk High
$4.36
52-wk Low
$2.00

Zweifach, Sanford 

Mr. Sanford (Sandy) Zweifach has been appointed Director at Compugen Ltd. effective June 11, 2018. His work experience includes the following roles: Founder and Chief Executive Officer of Nuvelution Pharma, Inc. (since 2015), Founder and Chief Executive Officer of Ascendancy Healthcare, Inc., Partner at Reedland Capital Partners (2005-2010), Chief Executive Officer of Pathways Diagnostics, Managing Director and Chief Financial Officer of Bay City Capital, President and Chief Financial Officer of Epoch Biosciences, Chairman of Lyric Pharmaceuticals Inc. and IMIDomics, S.L. and Director of Realm Therapeutics, Inc. He holds a Bachelor of Science degree in Biology from University of California San Diego and a Master of Science degree in Physiology from University of California, Davis. He is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --